Top StoriesBrief
Hospitals sue Trump administration to stop federal drug discount rebate pilot
The American Hospital Association has filed a lawsuit against the Trump administration over a plan to replace upfront drug discounts with after-the-fact rebates.
FTMQ Health, written by our newsroom0 views

The American Hospital Association is suing the Trump administration to halt a plan that would alter a federal drug discount program, STAT News reported on October 9. The lawsuit targets a pilot program designed to overhaul how the federal 340B drug discount system operates. [1][2]
According to STAT News, the proposed federal pilot would replace traditional upfront discounts on medications with after-the-fact rebates for participating providers. The American Hospital Association filed the legal action to stop the administration from testing this new model. [1][2]
The legal challenge involves public health policies overseen by the second administration of President Donald Trump. Robert F. Kennedy Jr. serves as the Secretary of Health and Human Services in the administration. [3][4]
In short
- The American Hospital Association filed a lawsuit against the Trump administration on October 9.
- The lawsuit aims to block a pilot program affecting the 340B federal drug discount program.
- The proposed federal plan would swap upfront drug discounts for after-the-fact rebates.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]STAT+: Hospitals sue – again – to halt Trump administration’s 340B rebate pilotSTAT News, 6h ago (the report this story comes from)
- [2]Hospitals sue – again – to halt Trump administration’s 340B rebate pilotSTAT, 6h ago
Background
- [3]Make America Healthy Again on Wikipedia
- [4]Domestic policy of the second Trump administration on Wikipedia
Our newsroom writes these reports with the help of software, from the 4 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
More in Top Stories
- Trial withholding hepatitis B vaccines from newborns approved in Guinea Bissau2h ago
- Unproven plague cures spread online following reports of death in Russia17h ago
- Royal College of Pharmacy ends sponsorship deal with Israeli drug firm21h ago
- Trump administration investigates nine universities over postdoctoral research visas1d ago
- Teenager receives first UK testicular tissue transplant to restore fertility1d ago
- Multiple barriers prevent vulnerable consumers from accessing nutrient rich diets2d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.